Clinical similarities among bradykinin-mediated and mast cell-mediated subtypes of nonhereditary angioedema: A retrospective study

Clinical and Translational Allergy

Volumn 5, Issue 1, 2015, Pages

  Schulkes, Karlijn J G ^a   Van Den Elzen, Mignon T ^a   Hack, Erik C ^a   Otten, Henderikus G ^a   Bruijnzeel Koomen, Carla A F M ^a   Knulst, André C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Angioedema; Drug associated; Idiopathic; Wheals

Indexed keywords

ANTIHISTAMINIC AGENT; BRADYKININ; CORTICOSTEROID;

ABSENTEEISM; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; BRADYKININ MEDIATED NON HEREDITARY ANGIOEDEMA; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; DYSPHAGIA; DYSPNEA; FACE DISORDER; FEMALE; GENITAL SYSTEM DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAST CELL MEDIATED NON HEREDITARY ANGIOEDEMA; OUTPATIENT; PHARYNX DISEASE; PRIORITY JOURNAL; PRODROMAL SYMPTOM; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; RETROSPECTIVE STUDY; SPEECH DISORDER; SWELLING; TERTIARY CARE CENTER; VISUAL ANALOG SCALE;

EID: 84978024391     PISSN: None     EISSN: 20457022     Source Type: Journal    
DOI: 10.1186/s13601-015-0049-8     Document Type: Article

References (27)

1. Zuraw BJ. Hereditary angioedema. N Engl J Med. 2008;359:1027-36.
2. Kaplan AP, Greaves MW. Angioedema. J Am Acad Dermatol. 2005;53(3):373-88.
3. Grattan CE. Urticaria, angio-oedema and anaphylaxis. Clin Med. 2002;2(1):20-3.
4. Zuberbier T, Aberer W, Asero R, Bindslev-Jensen C, Brzoza Z, Canonica GW. The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014;69:868-87.
5. Tan EK, Grattan CE. Drug-induced urticaria. Expert Opin Drug Saf. 2004;3(5):471-84.
6. Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy. 2014;69:602-16.
7. Longhurst H, Cicardi M. Hereditary angio-oedema. Lancet. 2012;379(9814):474-81.
8. Zuraw B, Cicardi M, Levy RJ, Nuijens JH, Relan A, Visscher S, et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. J Allergy Clin Immunol. 2010;126(4):821-7. e14.
9. Kusuma A, Relan A, Knulst AC, Moldovan D, Zuraw B, Cicardi M, et al. Clinical Impact of Peripheral Attacks in Hereditary Angioedema Patients. Am J Med. 2012;125(9):937. e17-24.
10. Zingale LC, Beltrami L, Zanichelli A, Maggioni L, Pappalardo E, Cicardi B, et al. Angioedema without urticaria: a large clinical survey. CMAJ. 2006;175(9):1065-70.
11. Bernstein JA, Moellman J. Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema. Int J Emerg Med. 2012;5(1):39.
12. Beltrami L, Zanichelli A, Zingale L, Vacchini R, Carugo S, Cicardi M. Longterm follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema. J Hypertens. 2011;29:2273-7.
13. Bertazzoni G, Spina MT, Scarpellini MG, Buccelletti F, De Simone M, Gregori M, et al. Drug-induced angioedema: experience of Italian emergency departments. Intern Emerg Med. 2014;9(4):455-62.
14. Magerl M, Brasch J, Förster U, Hauswald B, Mohr EB, Prässler J, et al. Diagnostics and exclusion of hereditary angioedema: a standarized approach for the practice. Hautarzt. 2012;63(7):567-72.
15. Reshef A, Prematta MJ, Craig TJ. Signs and symptoms preceding acute attacks of hereditary angioedema: results of three recent surveys. Allergy Asthma Proc. 2013;34(3):261-6.
16. Madsen F, Attermann J, Linneberg A. Epidemiology of Non-hereditary Angioedema. Acta Derm Venereol. 2012;92:449-581.
17. Agostoni A, Aygören-Pürsn E, Binkley KE, Blanch A, Bork K, Bouillet L, et al. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004;114:S51-S131.
18. Nzeako UC, Frigas E, Tremaine WJ. Hereditary angioedema: a broad review for clinicians. Arch Intern Med. 2001;161:2417-29.
19. Bork K, Meng G, Staubach P, Hardt J. Hereditary Angioedema: New Findings Concerning Symptoms, Affected Organs, and Course. Am J Med. 2006;119:267-74.
20. Lipozenčić J, Wolf R. Life-threatening severe allergic reactions: urticaria, angioedema, and anaphylaxis. Clin Dermatol. 2005;23(2):193-205.
21. Ferraro MF, Moreno AS, Castelli EC, Donadi EA, Palma MS, Arcuri HA, et al. A single nucleotide deletion at the C1 inhibitor gene as the cause of hereditary angioedema: insights from a Brazilian family. Allergy. 2011;66:1384-90.
22. Todd KH, Funk KG, Funk JP, Bonacci R. Clinical significance of reported changes in pain severity. Emerg Med. 1996;27:485-9.
23. Gallagher EJ, Bijur PE, Latimer C, Silver W. Reliability and validity of a visual analog scale for acute abdominal pain in the ED. Am J Emerg Med. 2002;20:287-90.
24. Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14:798-804.
25. Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain. 1997;72:95-7.
26. McMillan CV, Speight J, Relan A, Bellizzi L, Haase G, Cicardi M. Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview study. Patient. 2012;5(2):113-26.
27. Lam HY, van Hoffen E, Michelsen A, Guikers K, Van der Tas CH, Bruijnzeel-Koomen CA, et al. Cow's milk allergy in adults is rare but severe: both casein and whey proteins are involved. Clin Exp Allergy. 2008;38:995-1002.